Home > PRODUCTS > Focused libraries > Other
Other Focused Libraries

Other focused libraries

101 uncategorized Focused Libraries designed with Ligand-based approach are listed below. These libraries are proposed for screening in various research and drug development projects.

 

 

 

 

 

 

  • the libraries contain drug-like compounds only
  • all the compounds are in stock
  • cherry picking is available

 

You can sort data by any column and use "Filter" option to search library's name:

Loading data...
Name Number of compounds Approach Available on-line
Acetylcholine M2 receptor antagonist - Ligand-based Ligand-based -
Acetylcholine M3 receptor antagonist - Ligand-based Ligand-based -
Acetylcholinesterase (AChE) 828 Receptor-based Receptor-Based Search on-line search on-line
Acetylcholine muscarinic antagonist - Ligand-based Ligand-based -
Alpha 1 adrenoreceptor agonist - Ligand-based Ligand-based -
Alpha 1 adrenoreceptor antagonist - Ligand-based Ligand-based -
Alpha 1a adrenoreceptor antagonist - Ligand-based Ligand-based -
Alpha 2 adrenoreceptor agonist - Ligand-based Ligand-based -
Alpha adrenoreceptor agonist - Ligand-based Ligand-based -
Alpha adrenoreceptor antagonist - Ligand-based Ligand-based -
Dopamine autoreceptor agonist - Ligand-based Ligand-based -
Dopamine D3 agonist - Ligand-based Ligand-based -
Dopamine D3 antagonist - Ligand-based Ligand-based -
Dopamine D4 antagonist - Ligand-based Ligand-based -
Endothelin A receptor antagonist - Ligand-based Ligand-based -
Endothelin B receptor antagonist - Ligand-based Ligand-based -
Endothelin receptor antagonist - Ligand-based Ligand-based -
GABA A receptor agonist - Ligand-based Ligand-based -
Glucagon receptor antagonist - Ligand-based Ligand-based -
2,3 Oxidosqualene lanosterol cyclase inhibitor - Ligand-based Ligand-based -
5 Hydroxytryptamine 1 antagonist - Ligand-based Ligand-based -
5 Hydroxytryptamine 1A agonist - Ligand-based Ligand-based -
5 Hydroxytryptamine 1D antagonist - Ligand-based Ligand-based -
5 Hydroxytryptamine 2 agonist - Ligand-based Ligand-based -
5 Hydroxytryptamine 2A antagonist - Ligand-based Ligand-based -
5 Hydroxytryptamine 2C antagonist - Ligand-based Ligand-based -
5 Hydroxytryptamine 3 agonist - Ligand-based Ligand-based -
5 Hydroxytryptamine antagonist - Ligand-based Ligand-based -
5 Hydroxytryptamine uptake inhibitor - Ligand-based Ligand-based -
Acetyl CoA transferase inhibitor - Ligand-based Ligand-based -
Acetylcholine nicotinic agonist - Ligand-based Ligand-based -
Acetylcholine nicotinic antagonist - Ligand-based Ligand-based -
Acute neurologic disorders treatment - Ligand-based Ligand-based -
ADP ribose polymerase inhibitor - Ligand-based Ligand-based -
Adrenaline antagonist - Ligand-based Ligand-based -
Adrenaline uptake inhibitor - Ligand-based Ligand-based -
Aldose reductase inhibitor - Ligand-based Ligand-based -
Anti-Helicobacter pylori - Ligand-based Ligand-based -
Benzodiazepine agonist - Ligand-based Ligand-based -
Benzodiazepine agonist partial - Ligand-based Ligand-based -
Corticotropin releasing factor 1 receptor antagonist - Ligand-based Ligand-based -
Cyclic GMP phosphodiesterase inhibitor - Ligand-based Ligand-based -
Cyclooxygenase inhibitor - Ligand-based Ligand-based -
Dihydroorotate dehydrogenase inhibitor - Ligand-based Ligand-based -
Dihydropteroate synthase inhibitor - Ligand-based Ligand-based -
DNA topoisomerase inhibitor - Ligand-based Ligand-based -
Endothelial growth factor antagonist - Ligand-based Ligand-based -
Excitatory amino acid antagonist - Ligand-based Ligand-based -
Factor VIIa inhibitor - Ligand-based Ligand-based -
Gastrin inhibitor - Ligand-based Ligand-based -
Growth hormone agonist - Ligand-based Ligand-based -
Histamine antagonist - Ligand-based Ligand-based -
Histamine release inhibitor - Ligand-based Ligand-based -
Interleukin 8 antagonist - Ligand-based Ligand-based -
Irritable Bowel syndrome treatment - Ligand-based Ligand-based -
Kallikrein inhibitor - Ligand-based Ligand-based -
Lactamase C inhibitor - Ligand-based Ligand-based -
Leukotriene B4 antagonist - Ligand-based Ligand-based -
Leukotriene E4 antagonist - Ligand-based Ligand-based -
Lipase inhibitor - Ligand-based Ligand-based -
Lipid peroxidase inhibitor - Ligand-based Ligand-based -
Lipoxygenase inhibitor - Ligand-based Ligand-based -
Liver fibrosis treatment - Ligand-based Ligand-based -
Maillard reaction inhibitor - Ligand-based Ligand-based -
MAO inhibitor - Ligand-based Ligand-based -
Mediator release inhibitor - Ligand-based Ligand-based -
Neurokinin 1 antagonist - Ligand-based Ligand-based -
Neurokinin 3 antagonist - Ligand-based Ligand-based -
Neuropeptide antagonist - Ligand-based Ligand-based -
Neuropeptide Y antagonist - Ligand-based Ligand-based -
Non-steroidal antiinflammatory agent - Ligand-based Ligand-based -
Oxytocin antagonist - Ligand-based Ligand-based -
Para amino benzoic acid antagonist - Ligand-based Ligand-based -
Peroxisome proliferator-activated receptor agonist - Ligand-based Ligand-based -
Peroxisome proliferator-activated receptor gamma agonist - Ligand-based Ligand-based -
Phosphodiesterase inhibitor - Ligand-based Ligand-based -
Phosphodiesterase V inhibitor - Ligand-based Ligand-based -
Phospholipase A2 inhibitor - Ligand-based Ligand-based -
Phospholipase inhibitor - Ligand-based Ligand-based -
Platelet aggregation inhibitor - Ligand-based Ligand-based -
Polarisation inhibitor - Ligand-based Ligand-based -
Potassium channel antagonist - Ligand-based Ligand-based -
Prostaglandin antagonist - Ligand-based Ligand-based -
Prostaglandin synthase inhibitor - Ligand-based Ligand-based -
Protease inhibitor - Ligand-based Ligand-based -
Reverse transcriptase inhibitor - Ligand-based Ligand-based -
Ribonucleoside diphosphate reductase inhibitor - Ligand-based Ligand-based -
Ribonucleoside triphosphate reductase inhibitor - Ligand-based Ligand-based -
Ribonucleotide reductase inhibitor - Ligand-based Ligand-based -
S-adenosyl-L-methionine decarboxylase inhibitor - Ligand-based Ligand-based -
Sigma receptor antagonist - Ligand-based Ligand-based -
Stromelysin inhibitor - Ligand-based Ligand-based -
Substance P antagonist - Ligand-based Ligand-based -
Thromboxane A2 antagonist - Ligand-based Ligand-based -
Thromboxane antagonist - Ligand-based Ligand-based -
Thromboxane synthase inhibitor - Ligand-based Ligand-based -
TNF convertase inhibitor - Ligand-based Ligand-based -
Topoisomerase inhibitor - Ligand-based Ligand-based -
Vanilloid antagonist - Ligand-based Ligand-based -
VLA antagonist - Ligand-based Ligand-based -
Xanthine oxidase inhibitor - Ligand-based Ligand-based -

 

Otava's Target-Focused Libraries distribution chart
Name Number
Kinases 67
Proteases 12
GPCRs 24
Ion channels 3
Disease-based libraries 29
Epigenetic targets 6
Protein-Protein Interaction 2
Peptidomimetic 1
Nuclear Receptors 1
General Activities 127
Other 101

 

Learn more about other Focused Libraries available from Otava:

 

 

 

 

The libraries (DB, SD, XLS, PDF format) as well as price-list are available on request. Feel free to contact us or use on-line form below to send an inquiry if you are interested to obtain these libraries or if you need more information.

 

 

 

 

Need more information regarding this product? Send us an inquiry:


Name: *
Company: *
E-mail: *
Your message
(please specify name of the product
you are interested in):
*
Word Verification: